Management - Page 48 of 50 - Express Pharma

FSSA and the emerging OTC landscape

Regulatory woes of pharma SMEs

ACTA Down, but What Next?

Drug pricing norms: Cost or MRP based?

Venus Remedies: Reinventing R&D

Regulatory woes of pharma SMEs (Part I)

Back to the roots —Landscaping OTC opportunities in the Indian ayurveda market

A holistic view of the HPAPI opportunity

Unichem Laboratories: Steering through change

‘Successful marketing is impossible without relevant branding’